[1]
Facklam, R. (2002) What Happened to the Streptococci: Overview of Taxonomic and Nomenclature Changes. Clin Microb Rev, 15, 613-630.
http://dx.doi.org/10.1128/CMR.15.4.613-630.2002
[2]
Brandt, C.M. and Spellerberg, B. (2009) Human Infections Due to Streptococcus dysgalactiae Subspecies Equisimilis. Clin Infect Dis., 49, 766-772.
http://dx.doi.org/10.1086/605085
[3]
Vandamme, P., Pot, B., Falsen, E., Kersters, K. and Devriese, L.A. (1996) Taxaonomic Study of Lancefield Streptococcal Groups C, G, and L (Streptococcus dysgalactiae) and Proposal of S. dysgalactiae Subsp. Equisimilis Subsp. Nov. Int J Syst Bacteriol., 46, 774-781.
http://dx.doi.org/10.1099/00207713-46-3-774
[4]
Hashikawa, S., Iinuma, Y., Furushita, M., Ohkura, T., Nada, T., Torii, K., Hasegawa, T. and Ohta, M. (2004) Characterization of Group C and G Streptococcal Strains That Cause Streptococcal Toxic Shock Syndrome. J Clin Mi-crobiol., 42, 186-192.
http://dx.doi.org/10.1128/JCM.42.1.186-192.2004
[5]
Humar, D., Datta, V., Bast, D.J., Beall, B., De Azavedo, J.C.S. and Nizet, V. (2002) Streptolysin S and Necrotizing Infections Produced by Group G Streptococcus. The Lancet, 359, 124- 129.
http://dx.doi.org/10.1016/S0140-6736(02)07371-3
[6]
Minami, M., Ichikawa, M., Matsui, H., Hata, N., Wakiyama, N., Matsumoto, M., Ohta, M. and Hasegawa, T. (2011) Prevalence of a Streptococcal Inhibitor of a Complement-Medi- ated Cell Lysis-Like Gene (sicG) in Streptococcus dysgalactiae Subsp. Equisimilis. Curr Microbiol., 62, 884-887.
http://dx.doi.org/10.1007/s00284-010-9798-8
[7]
Ichikawa, M., Minami, M., Ohashi, M., Wakimoto, Y., Matsui, H. and Hasegawa, T. (2011) Clinical and Microbiological Analysis of Beta Hemolytic Streptococci during 2006-2010 at Nagoya University Hospital. Nagoya Med J., 51, 175-189.
[8]
Minami, M., Kuriyama, M., Ohshima, Y., Sakakibara, R., Imura, T., Morita, H., Kanemaki, N. and Ohta, M. (2015) Clinical Characteristics and Antimicrobial Susceptible Patterns of Streptococcus dysgalactiae Subsp. Equisimilius Isolates during 2009-2013 in Japan. Int. J. Curr. Microbiol. App. Sci., 4, 498-507.
[9]
Takahashi, T., Sunaoshi, K., Sunakawa, K., Fujishima, S., Watanabe, H. and Ubukata, K., Invasive Streptococcal Disease Working Group (2010) Clinical Aspects of Invasive Infections with Streptococcus dysgalactiae Ssp. Equisimilis in Japan: Differences with Respect to Streptococcus pyogenes and Streptococcus agalactiae Infections. Clin Microbiol Infect., 16, 1097-1103.
http://dx.doi.org/10.1111/j.1469-0691.2009.03047.x
[10]
Takahashi, T., Asami, R., Tanabe, K., Hirono, Y., Nozawa, Y., Chiba, N. and Ubukata, K. (2010) Clinical Aspects of Invasive Infection with Streptococcus dysgalactiae Subsp. Equisimilisin Elderly Patients. J Infect Chemother., 16, 68-71.
http://dx.doi.org/10.1007/s10156-009-0016-1
[11]
Clinical and Laboratory Standards Institute (2014) Performance Standards for Antimi-crobial Susceptibility Testing: 24st Information Supplement. Clinical and Laboratory Standards Institute M100-S24, Wayne.
[12]
Fuursted, K., Stegger, M., Hoffmann, S., Lambertsen, L., Andersen, P.S., Deleuran, M. and Thomsen, M.K. (2016) Description and Characterization of a Penicillin-Resistant Streptococcus dysgalactiae Subsp. Equisimilis Clone Isolated from Blood in Three Epidemiologically Linked Patients. J Antimicrob Chemother.
http://dx.doi.org/10.1093/jac/dkw320